Intellia Therapeutics, Inc. NTLA 深 滬
等待開盤 09-25 09:30:00 美东时间
11.94
-0.390
-3.16%
華盛通- 最 高12.15
- 今 開12.13
- 成交量 274.65万股
- 最 低 11.62
- 昨 收 12.33
- 總市值 16.73亿
- 52周最高 28.25
- 市盈率 靜 --
- 換手率 1.96%
- 52周最低 7.95
- 委 比 -31.50%
- 總股本 1.40亿
- 歷史最高 202.73
- 量 比 0.78
- 振 幅 4.30%
- 歷史最低 5.90
- 每 手 1
- 風險率 3.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
Intellia Therapeutics Enters Into $400M Non-Dilutive Senior Secured Term Loan Facility With OrbiMed
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that it has entered into a $400 million non-dilutive senior secured term loan facility with OrbiMed, a leadin...
09-04 20:51
美股大行评级 | 瑞杰金融维持英伟达"强力买入"评级，目标价从330美元升至352美元；瑞穗下调美光科技目标价从1375美元降至1300美元
今日重点评级关注：摩根大通：维持Ultragenyx Pharmaceutical"超配"评级，目标价从75美元升至80美元；瑞杰金融：维持英伟达"强力买入"评级，目标价从330美元升至352美元
08-26 08:37
Citizens Reiterates Market Outperform on Intellia Therapeutics, Maintains $30 Price Target
Citizens analyst Silvan Turkcan reiterates Intellia Therapeutics (NASDAQ:NTLA) with a Market Outperform and maintains $30 price target.
08-25 21:18
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
Evercore ISI Group Upgrades Intellia Therapeutics to Outperform, Raises Price Target to $24
Evercore ISI Group analyst Jonathan Miller upgrades Intellia Therapeutics (NASDAQ:NTLA) from In-Line to Outperform and raises the price target from $16 to $24.
08-07 20:25
财报速睇 | Intellia Therapeutics, Inc. 2026财年Q2营收0.08亿美元，同比下降42.9%；归母净利润亏损1.07亿美元，同比亏损扩大5.9%
华盛资讯8月6日讯，Intellia Therapeutics, Inc.公布2026财年Q2业绩，公司Q2营收0.08亿美元，同比下降42.9%，归母净利润亏损1.07亿美元，同比亏损扩大5.9%。
08-06 20:02
美股大行评级 | 阿斯麦、贝莱德、纽约梅隆银行、信达思、JB亨特运输服务、美国制商银行、PNC金融服务集团等获多家大行集体上调目标价
今日重点评级关注：瑞杰金融：维持Electrovaya"强力买入"评级，目标价从14美元升至22美元；BTIG：维持vTv Therapeutics"买入"评级，目标价从49美元升至57美元
07-17 11:35
This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Stifel analyst Nathan Jones downgraded Pentair PLC (NYSE:PNR) from Buy to Hold and cut the price ...
07-16 19:15
美股大行评级 | 潜在涨幅98.68%！DA Davidson上调Almonty Industries目标价至33美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持Almonty Industries"买入"评级，目标价从25美元升至33美元；Stifel：维持Nurix Therapeutics"买入"评级，目标价从34美元升至40美元
07-13 10:13
